Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's
Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs
The FDA's Orphan Drug Designation is granted to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
The nadAROSE and nadia3D kits address the needs of researchers exploring both agarose encapsulation and collagen-based hydrogel projects for the 3D cell culture space.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
